Not long ago, the FDA announced there's no longer a shortage of Ozempic, Wegovy, Zepbound or similar drugs used for weight ...

Obstructive sleep apnea or OSA affects nearly a billion people across the globe. It robs people of their sleep, they stop ...

Zepbound is also approved to treat severe obstructive sleep apnea (OSA) in adults with obesity. Zepbound can cause mild to serious side effects, but insomnia is not among the side effects reported ...

In 2024, the Food and Drug Administration (FDA) approved the first sleep apnea medication, Zepbound, for use by people with sleep apnea and obesity. When used in combination with proper diet and ...

Compounding pharmacies have been allowed to essentially make a cheaper version of Eli Lilly's Zepbound, but they have to stop ...

As obesity drug developers compete for the highest weight-loss efficacy, experts contend that overall health ...

A new study suggests blockbuster weight loss drugs Wegovy and Zepbound are not cost-effective at their current prices, despite the proven health benefits. The study, published in JAMA Health Forum and ...

"It's called GLP-1 receptor," said Dr. Atul Malhotra from the UC San Diego School of Medicine. It’s already FDA-approved to ...

Obesity was tied with an increased risk of developing 16 health outcomes, a large longitudinal study showed. Risks correlated ...

And Jackson doesn't need his sleep apnea machine anymore. (In December, the Food and Drug Administration approved Zepbound to treat sleep apnea.) "It is completely life-changing to take a bite of ...